findmyKOL

Rebecca Tung, MD

Basic profile

University of Central Florida

ORCIDNPI
RegionDavenport, FL · SoutheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2021Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rebecca Tung is a Dermatology physician affiliated with University of Central Florida. OpenAlex indexes 104 publications with 1,613 citations (h-index 22); ClinicalTrials.gov lists 4 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
104publications

Distinct works indexed by OpenAlex, matched via ORCID.

1,613citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

130 Ridge Center Dr Ste 203
Davenport, FL 338376416

Telephone

863-667-6647

Provider last certified this registry record 5 Mar 2026.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    46.9%
    RNA Synthetase Inhibitor Antibacterial36.9%
    Mupirocin100%
    Part D727 patients
    Opioid Agonist8.3%
    Hydrocodone-Acetaminophen100%
    Part D178 patients

    + 2 more classes in this area

  • Anti-infectives

    41.1%
    First-generation cephalosporins25.8%
    Cephalexin100%
    Part D515 patients
    Tetracycline-class Drug7.9%
    Doxycycline Hyclate100%
    Part D161 patients

    + 5 more classes in this area

  • Dermatology

    3.7%
    Corticosteroid3.7%
    Triamcinolone Acetonide100%
    Part D76 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”